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Abstract
In the rat, 5-HT1A receptors are found on medial septal cholinergic neurons. The effects of intraseptal infusions of the 5-
HT1A receptor agonist 8-OH-DPAT (8-hydroxy-2-(di-n-propyl-amino)-tertralin) were assessed on reference memory
performances in a water maze. Compared with vehicle infusions, 0.5 and 4 mg of 8-OH-DPAT signi®cantly impaired
(but did not prevent) acquisition of the task and probe-trial performances. The results suggest that activation of 5-TH1A
receptors in the (medial) septal area impairs spatial learning, perhaps directly by reducing the hippocampal cholinergic
tonus, or indirectly by an effect on anxiety. q 2000 Elsevier Science Ireland Ltd. All rights reserved.
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Serotonin may modulate cholinergic function in different
regions of the brain and interactions between both neuro-
transmission systems may be important for learning and
memory (e.g. [3]). The medial septum (MS) area, which
provides the hippocampus with cholinergic ®bers and is
critical for memory [20], is a potential support for such
interactions. In the rat, it receives serotonergic ®bers from
the raphe nuclei [1]. Moreover, serotonin-containing term-
inals synapse on septohippocampal neurons [15]. Serotonin
may act on MS neurons by activating 5-HT1A receptors
which are in high density in this structure [18]. A part of
these receptors may be located postsynaptically [4,10,18],
and a subpopulation of cholinergic neurons in the MS
express 5-HT1A receptors [9]. Little is known about the
role of these receptors in behavior and memory. Intraseptal
injections of the speci®c 5-HT1A agonist 8-OH-DPAT (8-
hydroxy-2-(di-n-propyl-amino)-tertralin) increase maternal
aggressive behavior [5] and in¯uence anxiety [6,13,14].
When infused into the lateral septum (LS), 8-OH-DPAT
impairs retention of passive avoidance [11]. However, noth-
ing is known about the involvement of septal 5-HT1A recep-
tors in spatial learning. Using a reference memory task in
the water maze, we investigated whether intraseptal infu-
sions of 8-OH-DPAT could alter spatial learning.
All procedures involving animals were conducted accord-
ing to international laws and policies. The study used 40
three-month old Long-Evans male rats (CERJ, France),
housed individually in transparent cages (room temperature
218C, lights on from 07:00 to 19:00 h). Microinjector guide
canula were implanted in all rats, 6±7 days before testing,
under equithesin anesthesia (3.5 ml/kg, i.p.). The stereotaxic
coordinates were (in mm) A  10.8, L  11.1 and V 
25.3 from Bregma [17], with a mediolateral angle of 108
and the incisor bar at 3 mm underneath the interaural line.
As the microinjector needle was 1mm longer than the guide
canula, the tip of the latter was placed 1 mm above the
injection site.
Spatial learning was assessed in a water maze using a
protocol placing emphasis on reference memory [8]. The
platform (B 11 cm), lowered 1 cm underneath water opaci-
®ed with powdered milk, remained at the same place for all
acquisition trials. During ®ve days, the rats underwent four
consecutive trials/day, starting each time from a different
position at the edge of the pool (B 160 cm). Each of the 19
acquisition trials was limited to 60 s, after which the rats that
did not ®nd the platform were placed on it by the experi-
menter. Escape latencies and distances swum from the start-
ing point to the platform were collected. For the probe trial
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(trial 20), the platform was removed from the pool. During
60 s, the distance swum and time spent by the rat in each
quadrant were recorded.
The rats were allocated to one of four groups: CSF,
DPAT0.5, DPAT4 and SHAM. CSF rats (n  9) were
microinjected into the MS with arti®cial cerebrospinal
¯uid (aCSF: Na 150, K 3.0, Ca 1.4, Mg 0.8, P 1.0, Cl 155,
in mM), DPAT0.5 rats (n  11) with 0.5 mg and DPAT4
rats (n  11) with 4.0 mg of 8-OH-DPAT (Sigma-Aldrich,
USA) in aCSF. The microinjections (0.5 ml in 1 min) were
performed 10 min before testing. The nine remaining rats
(SHAM) were handled as the others, but did not receive
injections. The rats were tested according to a random
order repeated on each day.
At the end of testing, the rats were sacri®ced, their brain
®xed with a 4% paraformaldehyde solution perfused trans-
cardially and cut into 30-mm thick coronal sections.
Sections were stained with cresyl violet, or for acetylcholi-
nesterase (AChE) using acetylthiocholine iodide (4 mM) as
the substrate and ethopropazine (0.3 mM) to inhibit non-
speci®c cholinesterases.
For the acquisition trials, daily mean escape latencies,
distances and velocities were compared by a two-way analy-
sis of variance (ANOVA) for repeated measures (Group £
Day). For the probe trial, time spent and distances swum in
each quadrant, and mean velocities during the trial were
compared by one-way ANOVAs. Two-by-two comparisons
used the Newman±Keuls test. Rats with inappropriate
implantation of the guide canula were discarded from analy-
sis (CSF, n  2; DPAT0.5, n  1).
Appropriate injection sites are shown in Fig. 1A±D. No
important histological change was observed within the MS
region, except a slight gliosis restricted to the injection site
and the canula track overlying the MS (Fig. 1E,F). AChE-
staining did not show any noticeable difference among the
groups within the MS or within the hippocampal formation
(data not illustrated).
Comparison of acquisition and probe-trial performances,
as well as the velocities, in SHAM and CSF rats showed no
signi®cant difference (F1;14 , 2:3, P . 0:15 in all cases).
From day 1 to 5, mean values ^ SEM of SHAM rats were:
distances (cm): 1080 ^ 102, 643 ^ 89, 600 ^ 71, 482 ^ 96,
330^ 48; escape latencies (s): 50.5^ 3.4, 24.8^ 3.7, 23.5^
3.2, 17.7 ^ 3.2, 13.6 ^ 1.7. During the probe trial, we found
629^ 29 cm swum and 27^ 2.0 s spent in the probe quadrant
(where the platform was during the acquisition trials). Further
analyses considered performances of CSF, DPAT0.5 and
DPAT4 rats. The velocities did not differ signi®cantly
among the three groups, whether during the acquisition trials
or the probe trial, which did not differ from each other (CSF,
26.2^ 0.8; DPAT0.5, 26.9^ 0.5; DPAT4, 26.6^ 0.5 cm/s).
During the acquisition trials, there was a signi®cant decrease
in distances (F4;100  43:5, P , 0:0001) and escape latencies
(F4;100  83:3, P , 0:0001) over the days (Fig. 2). The
Group £ Day interaction was not signi®cant (F8;100 ,1.44 in
each case). There was also a signi®cant Group effect on
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Fig. 1. (A±D) Schematic representation of appropriate injection
sites on coronal sections through the medial septum; coordi-
nates in mm from Bregma [17]. Open diamonds, CSF group
(n  7); closed circles, DPAT0.5 group (n  10); open circles,
DPAT4 group (n  11). MS, medial septum; VDB, vertical limb
of diagonal band of Broca; LS, lateral septum; cc, corpus callo-
sum; CPu, caudate putamen. (E,F) Largest damage due to the
canula and injections at anteriorities where most injection sites
were located (shaded area).
distances (F2;25  3:96, P , 0:05): distances in DPAT0.5
and DPAT4 groups did not differ from each other, but were
higher than in the CSF group (P , 0:05; Fig. 2). A marginal
effect was found on escape latencies (F2;25  3:23,
P  0:057; Fig. 2).
During the probe trial (Table 1), a global Group effect
was found on distances swum (F2;25  7:59, P , 0:01) and
time spent (F2;25  11:01, P , 0:001) in the probe quad-
rant, but also in the opposite quadrant (F2;25  4:74 and
7.69, respectively, P , 0:05). All statistics are shown in
Table 1. When compared to CSF rats, both DPAT0.5 and
DPAT4 rats spent signi®cantly less time (P , 0:01) and
swum a shorter distance (P , 0:05) in the probe quadrant.
Conversely, they spent more time (P , 0:01) and swam
longer distances (P , 0:05) in the opposite quadrant. In
each quadrant, performances of DPAT0.5 and DPAT4 rats
did not differ signi®cantly from each other.
Our results show that intraseptal microinjections of 8-
OH-DPAT impair, but do not prevent, spatial learning in a
water-maze task. During the probe trial, rats infused with 8-
OH-DPAT did not search for the platform as accurately as
the controls. These effects being not different between
doses, they seem close to maximal already at the lowest
dose. Furthermore, as 8-OH-DPAT had no effect on the
rats' velocity, it seems that the drug-induced impairment
did not re¯ect sensorimotor perturbations. This interpreta-
tion is strengthened by the fact that the effects were most
pronounced on distances, a variable considered poorly
sensitive towards sensorimotor biases [12]. Nevertheless,
this interpretation requires further support, for instance by
testing rats with a visible platform.
Regarding the location of the injection sites, the effects
observed could be due to diffusion of 8-OH-DPAT towards
structures close to the MS, such as the LS which seems also
implicated in spatial memory [7] and where 5-HT1A recep-
tors have been identi®ed [18]. To our knowledge, there are
very few data concerning mnesic effects of 8-OH-DPAT
injections into the LS. Lee et al. [11] showed that such
injections impaired retention of passive avoidance. Alterna-
tively, 8-OH-DPAT may have reached the hippocampus
through the ventricles. When infused directly into the hippo-
campus, 8-OH-DPAT induces spatial memory impairments
[2]. Nevertheless, the de®cits that we observed may not be
due to activation of hippocampal 5-HT1A receptors. Intra-
hippocampal infusions of 2 or 5 mg 8-OH-DPAT are
required to impair spatial discrimination in a water-maze
task, whereas 0.4 mg is ineffective [2]. In our experiment,
an intraseptal dose of 0.5 mg induced clear-cut learning
de®cits, but was certainly insuf®cient to allow a signi®cant
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Table 1
Probe triala
Group Probe quadrant Quadrant 1 Quadrant 2 Quadrant 4
Distance (cm)
CSF (n  7) 747 ^ 56 215 ^ 25 407 ^ 43 280 ^ 48
DPAT0.5 (n  10) 621 ^ 41* 336 ^ 32* 415 ^ 27 320 ^ 25
DPAT4 (n  11) 522 ^ 52** 353 ^ 38* 389 ^ 29 359 ^ 21
Time (s)
CSF (n  7) 28.5 ^ 1.6 7.5 ^ 0.9 14.3 ^ 1.7 9.8 ^ 1.7
DPAT0.5 (n  10) 22.3 ^ 1.6** 11.6 ^ 1.0** 15.0 ^ 0.9 11.0 ^ 0.9
DPAT4 (n  11) 19.4 ^ 1.6** 13.2 ^ 1.4** 14.2 ^ 1.0 13.1 ^ 0.7*
a Mean ^ SEM distance swum and time spent in each quadrant of the pool in CSF, DPAT0.5 and DPAT4 rats. Quadrant 1 is opposite to
the probe quadrant. *P , 0:05 and **P , 0:01 vs. CSF.
Fig. 2. Acquisition trials. Daily mean ^ SEM distances and
escape latencies found in CSF (n  7), DPAT0.5 (n  10) and
DPAT4 (n  11) rats.
amount of 8-OH-DPAT to reach the hippocampus. More-
over, in a three panel-runway task, intrahippocampal infu-
sion of 10 mg of 8-OH-DPAT impaired working but not
reference memory [16]; in the present experiment, reference
memory was clearly impaired. Finally, in a recent experi-
ment performed in our laboratory with testing conditions
identical to ours (Lazaris et al., unpublished observations),
spatial learning was not prevented by the infusion of 2.5 mg
of 8-OH-DPAT into each dorsal hippocampus.
Intraseptal infusions of 8-OH-DPAT also in¯uence anxi-
ety [6,13,14]. As the Morris water-maze task is based on
aversive motivations, it cannot be ruled out that our rats
were in¯uenced by effects of 8-OH-DPAT on anxiety.
However, as 8-OH-DPAT was described to have anxiogenic
or anxiolytic properties, depending on the dose, the gender
and the test used [6,13], such a possibility requires further
investigations, particularly because anxiety can interfere
with the ef®ciency of spatial memory in rodents [14].
Based on immunohistochemical data and the involvement
of hippocampal cholinergic function in spatial cognition,
another speculation might consider the regulation of hippo-
campal acetylcholine (ACh) release through 5-HT1A recep-
tors located on cholinergic neurons in the MS which, for
some, receive serotonergic inputs [9,15]. These receptors
are negatively coupled to adenylyl cyclase and inhibit septal
neurons activity in vitro [19]. Thus, in the present study,
intraseptal injections of 8-OH-DPAT might have reduced
the hippocampal cholinergic tonus and induced memory
de®cits. To further analyze this issue, determination of
hippocampal ACh release after intraseptal infusion of 8-
OH-DPAT is required.
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